acquired aplastic anemia

acquired aplastic anemia

See Aplastic anemia.
References in periodicals archive ?
Acquired aplastic anemia other acquired bone marrow failure disorder and dyserythropoiesis.
Intrinsic impairment of CD4+CD25+ regulatory T cells in acquired aplastic anemia.
Patients were divided into five disease groups such as acute leukemia, thalassemia major, congenital or acquired aplastic anemia, coagulation factor deficiency (factor II, VII, VIII, IX, X, XI and vonWillebrand factor deficiencies) and other anemias (such as hereditary spherocytosis, sickle cell anemia).
Acquired aplastic anemia also occurs secondary to another disease, such as reactions to benzene, arsenic, chloramphenicol (Chloromycetin[R]), phenytoin (Dilantin[R]), and antimetabolite chemotherapeutic drugs (6-mercaptopurine, vincristine, and busulfan).
A table of contents lists the longer entries; among these are acquired aplastic anemia, fibronolysis, folic acid, gene therapy, leukemogenesis, myeloma, and spleen.
In our previous study of a small number of patients, p53 protein was not overexpressed in acquired aplastic anemia, while it was commonly overexpressed in RA.
The first cohort consisted of 59 Fanconi patients (30 males and 29 females; median age, 13 years; age range, 1-53 years) and 27 non-Fanconi patients (9 males and 18 females; median age, 26 years; age range, 5-56 years) with acquired aplastic anemia (n = 19), paroxysmal nocturnal hemoglobinuria (n = 2), dyskeratosis congenita (n = 3), Diamond-Blackfan anemia (n = 1), Schwachman syndrome (n = 1), or Glanzmann disease (n = 1).
Objective: Immunosuppressive treatment (IST) is an alternative for children with acquired aplastic anemia (AA) that do not have HLA-matched donors.